Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease.
The accuracy of dobutamine stress echocardiography (DSE) for the diagnosis of coronary artery disease (CAD) has not been yet evaluated in women. We studied the effect of gender on the accuracy of DSE for the diagnosis of CAD in 306 consecutive patients (210 men and 96 women) with limited exercise capacity and suspected myocardial ischemia who underwent coronary angiography within 3 months of DSE. There were no serious complications during DSE. Men had a higher prevalence of nonsustained ventricular tachycardia (7% vs 0.03%, p <0.05) and supraventricular tachycardia (9% vs 0.03%, p <0.05) during the test compared with women. Peak stress rate-pressure product was not different in men and women (18,140 +/- 4,187 vs 18,543 +/- 4,223). Significant CAD (> or =50% luminal diameter stenosis) was present in 171 men (81%) and in 62 women (65%, p <0.005). The sensitivity, specificity, and accuracy of ischemic pattern at DSE for the diagnosis of significant CAD were 76% (confidence interval [CI] 67 to 84), 94% (CI 89 to 99), and 82% (CI 75 to 90) in women and 73% (CI 67 to 79), 77% (CI 71 to 83), and 74% (CI 68 to 80) in men, respectively. Overall specificity was higher in women than in men (p <0.05). Regional accuracy of DSE was significantly higher in women than in men in the 3 arterial regions (84% [CI 79 to 88] vs 75% [CI 72 to 79], p <0.005). It is concluded that DSE is a safe and feasible method for the diagnosis of CAD in women. The overall specificity and the regional accuracy of DSE are higher in women than in men. Further studies are required to evaluate the functional significance of these findings and their reproducibility in different patient populations.
Elhendy
A
A
Thoraxcenter, University Hospital-Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
Geleijnse
M L
ML
van Domburg
R T
RT
Nierop
P R
PR
Poldermans
D
D
Bax
J J
JJ
TenCate
F J
FJ
Nosir
Y F
YF
Ibrahim
M M
MM
Roelandt
J R
JR
D002316:Cardiotonic Agents / Q000009:adverse effects; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D004280:Dobutamine / Q000009:adverse effects; D004452:Echocardiography / Q000009:adverse effects / Q000379:methods; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000453:epidemiology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D015203:Reproducibility of Results; D012449:Safety; D012680:Sensitivity and Specificity; D012727:Sex Characteristics; D013610:Tachycardia / Q000139:chemically induced / Q000453:epidemiology
D002316:Cardiotonic Agents; D004280:Dobutamine